目的:从产品开发角度分析全球合成生物学发展现状和趋势。方法:在伍德罗·威尔逊国际学者中心的合成生物学产品和应用清单(synthetic biology products and applications inventory)的数据基础上,对全球合成生物学产品的开发状态、市场应用和发展前景等进行补充检索和分析。结果:至2015年,全球至少已有81家企业(或研究机构)的116种合成生物学产品得到了市场应用开发,主要开发者为美国企业(或研究机构),产品主要集中于化学和医药领域。结论:合成生物学实现了从生物学分析向生物学合成的范式转移,其产品开发将给一系列的行业带来深刻的变革。
Objective: To analysis status and trends of synthetic biology in the perspective of product developments. Methods: Based on the Synthetic Biology Products and Applications Inventoryunveiledby Woodrow Wilson International Center for Scholars ' Synthetic Biology Project,supplementary search and analysison development phase,potential applications and prospect for the future were performed. Results: To 2015,at least81 companies( or research institutions),mainly US,with 116 synthetic biology products have been developed.The products mainly concentrated in chemicals and medicines. Conclusion: Synthetic biology has created a paradigm shift whereby the analysis of biology is being supplanted by its synthesis, and their product developments have the potential to significantly impact approaches across a variety of industries.